Learning whether to subtract beta-blockers: it's about time.
Journal Article (Editorial)
Proposed framework for foundational and provisional secondary prevention therapy over time in low-risk post-MI patients. Foundational therapies should be considered in all patients without contraindications, while provisional therapies should be considered in selected patients with comorbidities or post-infarction complications. The horizontal time axis proposes duration of therapies and timeframes for pharmacotherapeutic re-assessment, and should be responsive to the temporal evolution of post-MI risk and events. ADP, adenosine diphosphate receptor inhibitors; ASA, acetylsalicylic acid; CKD, chronic kidney disease; DM, diabetes mellitus; HTN, hypertension; RAAS, renin-angiotensin-aldosterone system; RCT, randomized controlled trials; TG, triglyceride. *Pending guideline recommendations.
- van Diepen, S; Armstrong, PW
- March 1, 2021
Volume / Issue
- 42 / 9
Start / End Page
- 915 - 918
Electronic International Standard Serial Number (EISSN)
Digital Object Identifier (DOI)